Your search returned 574 results.

Results
	501.	Advances in pharmacotherapy for the treatment of gout. [electronic resource] by Robinson, Philip C Dalbeth, Nicola Producer: 20150615 In: Expert opinion on pharmacotherapy vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	502.	Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data. [electronic resource] by Singh, Jasvinder A Cleveland, John D Producer: 20200515 In: Annals of the rheumatic diseases vol. 79 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	503.	Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK. [electronic resource] by Nomura, Johji Busso, Nathalie Ives, Annette Tsujimoto, Syunsuke Tamura, Mizuho So, Alexander Yamanaka, Yoshihiro Producer: 20140714 In: PloS one vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	504.	[Hyperuricemia, gout, pseudogout and concomitant diseases]. [electronic resource] by Schmidt, B M W Wagner, A D Producer: 20120118 In: Deutsche medizinische Wochenschrift (1946) vol. 136 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	505.	Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients (NU-FLASH Trial). [electronic resource] by Sezai, Akira Soma, Masayoshi Nakata, Kin-ichi Hata, Mitsumasa Yoshitake, Isamu Wakui, Shinji Hata, Hiroaki Shiono, Motomi Producer: 20140213 In: Circulation journal : official journal of the Japanese Circulation Society vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	506.	Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study. [electronic resource] by Oyama, Jun-Ichi Tanaka, Atsushi Sato, Yasunori Tomiyama, Hirofumi Sata, Masataka Ishizu, Tomoko Taguchi, Isao Kuroyanagi, Takanori Teragawa, Hiroki Ishizaka, Nobukazu Kanzaki, Yumiko Ohishi, Mitsuru Eguchi, Kazuo Higashi, Yukihito Yamada, Hirotsugu Maemura, Koji Ako, Junya Bando, Yasuko K Ueda, Shinichiro Inoue, Teruo Murohara, Toyoaki Node, Koichi Producer: 20170103 In: Cardiovascular diabetology vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	507.	Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic Model. [electronic resource] by Hill-McManus, Daniel Marshall, Scott Soto, Elena Lane, Steven Hughes, Dyfrig Producer: 20190102 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	508.	Dual inhibition of NADPH oxidases and xanthine oxidase potently prevents salt-induced stroke in stroke-prone spontaneously hypertensive rats. [electronic resource] by Ngarashi, Davis Fujikawa, Koichi Ferdaus, Mohammed Zubaerul Zahid, Hasan M Ohara, Hiroki Nabika, Toru Producer: 20200908 In: Hypertension research : official journal of the Japanese Society of Hypertension vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	509.	Protective effect of febuxostat in sepsis-induced liver and kidney injuries after cecal ligation and puncture with the impact of xanthine oxidase, interleukin 1 [electronic resource] by Ibrahim, Y F Fadl, R R Ibrahim, Sae Gayyed, M F Bayoumi, Ama Refaie, Mmm Producer: 20210210 In: Human & experimental toxicology vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	510.	Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats. [electronic resource] by Shirakura, Takashi Nomura, Johji Matsui, Chieko Kobayashi, Tsunefumi Tamura, Mizuho Masuzaki, Hiroaki Producer: 20170221 In: Naunyn-Schmiedeberg's archives of pharmacology vol. 389 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	511.	The influence of febuxostat on coronary artery endothelial dysfunction in patients with coronary artery disease: A phase 4 randomized, placebo-controlled, double-blind, crossover trial. [electronic resource] by Hays, Allison G Iantorno, Micaela Schär, Michael Lai, Shenghan Czarny, Matthew Breton, Elayne Palmer, Robert N Whelton, Andrew Weiss, Robert G Gerstenblith, Gary Producer: 20190130 In: American heart journal vol. 197 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	512.	Risk of cutaneous adverse reactions associated with allopurinol or febuxostat in real-world patients: A nationwide study. [electronic resource] by Lin, Chih-Wan Huang, Wei-I Chao, Pi-Hui Chen, Wen-Wen Hsiao, Fei-Yuan Producer: 20190805 In: International journal of clinical practice vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	513.	Changeover Trial of Febuxostat and Topiroxostat for Hyperuricemia with Cardiovascular Disease: Sub-Analysis for Chronic Kidney Disease (TROFEO CKD Trial). [electronic resource] by Sezai, Akira Unosawa, Satoshi Taoka, Makoto Osaka, Shunji Sekino, Hisakuni Tanaka, Masashi Producer: 20200922 In: Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	514.	Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricemia. [electronic resource] by Nishizawa, Tohru Taniura, Takehito Nomura, Shosaku Producer: 20160810 In: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	515.	Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout. [electronic resource] by Hill-McManus, Daniel Marshall, Scott Soto, Elena Hughes, Dyfrig A Producer: 20200511 In: Clinical pharmacology and therapeutics vol. 106 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	516.	Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort. [electronic resource] by Singh, Jasvinder A Akhras, Kasem S Shiozawa, Aki Producer: 20160119 In: Arthritis research & therapy vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	517.	A repeated oral administration study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with impaired renal function in Japan: pharmacokinetic and pharmacodynamic study. [electronic resource] by Hosoya, Tatsuo Tatsuo, Hosoya Ohno, Iwao Iwao, Ohno Producer: 20111201 In: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	518.	Evaluation and treatment of gout as a chronic disease. [electronic resource] by Perez-Ruiz, Fernando Herrero-Beites, Ana Maria Producer: 20130301 In: Advances in therapy vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	519.	Febuxostat, a novel inhibitor of xanthine oxidase, reduces ER stress through upregulation of SIRT1-AMPK-HO-1/thioredoxin expression. [electronic resource] by Kim, Hyosang Baek, Chung Hee Chang, Jai Won Yang, Won Seok Lee, Sang Koo Producer: 20201208 In: Clinical and experimental nephrology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	520.	Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study. [electronic resource] by Takai, Mihoko Yamauchi, Takahiro Ookura, Miyuki Matsuda, Yasufumi Tai, Katsunori Kishi, Shinji Yoshida, Akira Iwasaki, Hiromichi Nakamura, Toru Ueda, Takanori Producer: 20150324 In: Anticancer research vol. 34 Availability: No items available. Save to lists Add to cart (remove)

First
Previous
17
18
19
20
21
22
23
24
25
26
27
28
29
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 574 results.